Fig. 2
From: CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
CRISPR/Cas9 applications in cancer research and therapy. Knockout (KO), T-cell receptor (TCR), chimeric antigen receptor (CAR)-T cell, β2-microglobulin (B2M), programmed cell death protein 1 (PD1 or PDCD1), lymphocyte activating gene 3 (LAG-3), transforming growth factor-beta receptor (TGF-βR), diacylglycerol (DAG), Epstein–Barr virus (EBV), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), cancer stem cell (CSC)